• Users Online: 174
  • Print this page
  • Email this page
Year : 2021  |  Volume : 12  |  Issue : 1  |  Page : 31-33

Post-COVID-19 guillain-barre syndrome: A distinct neurological entity

1 Department of Medicine, Lady Hardinge Medical College & SSK Hospital, New Delhi, India
2 Department of Medicine, Bhagwan Mahavir Hospital, New Delhi, India

Correspondence Address:
Dr. Ritika Sud
Department of Medicine, LHMC, Shaheed Bhagat Singh Marg, New Delhi - 110 001
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/injms.injms_142_20

Rights and Permissions

SARS-CoV-2, the causative agent for COVID-19, originated in China in the fall of 2019 and soon became a pandemic engulfing the entire world, presenting with a myriad of presentations from asymptomatic to severe disease with acute respiratory distress syndrome and multiple organ dysfunction and severe inflammatory response. Little is understood about the new virus and its pathogenesis, and it is too early to ascertain its long-term sequelae at this point in time. New associations and clinical problems keep appearing with the new virus and thus we also got to encounter three cases of acute inflammatory demyelinating polyneuropathy (AIDP) in patients following COVID-19 infection. This case series aims to convey clinicians that AIDP can be seen in patients with COVID-19, particularly during the recovery phase, and thus not to miss it as postviral fatigue and malaise.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded393    
    Comments [Add]    
    Cited by others 4    

Recommend this journal